TrialAnnals of the rheumatic diseases2024

Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study.

Cynthia Aranow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.